INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo GULF CALCIUM GLUCONATE 300 mg (Tablets)

SCHEDULING STATUS:
Unscheduled

PROPRIETARY NAME
(and dosage form):

GULF CALCIUM GLUCONATE 300 mg (Tablets)

COMPOSITION:
300 mg
Calcium Gluconate per tablet
Contains sugar: 60 mg per tablet

PHARMACOLOGICAL CLASSIFICATION:
A. 24 Mineral substitutes, electrolytes

PHARMACOLOGICAL ACTION:
Calcium is an essential body electrolyte. It is involved in the maintenance of normal muscle and nerve function, is essential for normal cardiac function, and is essential to the clotting of blood. Adequate amounts are present in the average diet except for growing children and pregnant or lactating women.

INDICATIONS:
Calcium salts are used mainly in the treatment of Calcium deficiency and hypocalcaemia. Hypocalcaemia may occur in malnutrition or dietary deficiency.

CONTRA-INDICATIONS:
Calcium enhances the effect of digitalis on the heart and may precipitate digitalis intoxication.

WARNINGS:
THE TABLETS SHOULD BE CHEWED BEFORE BEING SWALLOWED. THE TABLETS SHOULD NOT BE TAKEN OVER PROLONGED PERIODS WITHOUT MEDICAL ADVICE.

DOSAGE AND DIRECTIONS FOR USE:
Adults:         Chew three tablets up to three times daily as required or as prescribed.
Children:         100 to 125 mg/Kg body weight. The dose may be repeated up to four times daily.

SIDE EFFECTS AND SPECIAL PRECAUTIONS:
When given by mouth calcium salts may cause constipation. Calcium salts should be given with caution to patients with impaired renal function or a history of renal stone formation. Calcium salts reduce the absorption of tetracycline.

KNOWN SYMPTOMS OF OVER DOSAGE AND PARTICULARS OF ITS TREATMENT:
Symptoms of hypercalcaemia may include anorexia, nausea, vomiting, constipation, abdominal pain, muscle weakness, thirst, polyuria, drowsiness, confusion, leg pain due to demineralisation, nephrocalcinosis, loss of renal concentrating capacity, renal calculi, and in severe cases, cardiac arrhythmias, coma an cardiac arrest.
The treatment of overdosage is to reduce the calcium intake to a minimum, and large doses of water are given to combat dehydration and reduce deposition calcium. In mild to moderate hypercalcaemia, sodium phosphates may be give by mouth. In more severe cases of overdosage, the patient should be referred to a hospital to receive specialised treatment.

IDENTIFICATION:
A pink, raspberry flavoured, round, flat, tablet scored on one side

PRESENTATION:
White HDPE containers of 1000 tablets
Patient ready packs (PRP) of 28 tablets

STORAGE INSTRUCTIONS:
Store below 25ºC in airtight containers. Protect from heat, light and moisture. Keep container tightly closed.
KEEP OUT OF REACH OF CHILDREN

REGISTRATION NUMBER:
E1416 (Act 101 of 1965)

NAME AND BUSINESS ADDRESS OF THE APPLICANT:
GULF DRUG COMPANY (PTY) LTD.
22 BURNSIDE DRIVE
OLD MILL INDUSTRIAL PARK
MOUNT EDGECOMBE
4300

www.gulfdrug.co.za

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
March 1998

New addition to this site: July 2010
Source: Pharmaceutical Industry

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2010